Velarion Records
Free. Unsubscribe any time.

Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals, Inc. filed 28 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 50 transactions and 435,853 shares. None carries the SEC's AFF10B5ONE flag; all 28 name a plan in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Mirum Pharmaceuticals, Inc. 50

Adoption dates in Mirum Pharmaceuticals, Inc. 7

Results prints in Mirum Pharmaceuticals, Inc. 9

Trades before a print in Mirum Pharmaceuticals, Inc. 1

Interval to Mirum Pharmaceuticals, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Mirum Pharmaceuticals, Inc. states

Filing text: “10b5-1 Plan adopted by the reporting person on March 9, 2026”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.